title: [Factors predicting the response to alpha-interferon therapy in patients with chronic hepatitis C].
abstract: Objective of the study was to identify predictive factors of response to treatment with interferon in patients with anti-HCV positive chronic liver disease. 92 anti-HCV positive patients, 51 with chronic hepatitis and 41 with active cirrhosis, were treated for 12 months with recombinant alpha 2a interferon at a starting dose of 6 MU TIW/6 months, followed by 3 MU TIW/6 months. Patients were considered responders (RS) when they presented normal serum ALT values both at the end of treatment and after 6 months of follow-up; relapsers (RC) those with normal ALT values at the end of treatment but with increase during the 6 months of follow-up and non-responders (NR) patients who had no beneficial effect on ALT levels during treatment. 21 patients were RS, 11 RC and 60 cases NR. Univariate analysis of pre-treatment factors showed that response to interferon was associated with absence of cirrhosis and lower gamma-GT levels in RS than in RC. Multiple logistic regression of these variables showed that gamma-GT levels and absence of cirrhosis were the only independent factors associated with response to treatment. In conclusion, in our series of patients, only two factors were confirmed useful in predicting response to interferon treatment and it is concluded that they must always be evaluated before starting treatment with interferon which is not without side effects and may not have beneficial effect.
authors.affiliation: Cattedra di Medicina Interna, Università, Palermo.
authors.forename: M
authors.initials: M
authors.lastname: Soresi
authors.forename: S
authors.initials: S
authors.lastname: Tripi
authors.forename: A
authors.initials: A
authors.lastname: Cartabellotta
authors.forename: G
authors.initials: G
authors.lastname: di Gaetano
authors.forename: A
authors.initials: A
authors.lastname: Carroccio
authors.forename: S
authors.initials: S
authors.lastname: Amato
authors.forename: G
authors.initials: G
authors.lastname: Migneco
authors.forename: G
authors.initials: G
authors.lastname: Montalto
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D000917:Antibody Formation / Q000187:drug effects; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy* / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000276:immunology*; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D018937:Hepatitis C Antibodies; D016898:Interferon-alpha
vernacular_title: Fattori predittivi di risposta al trattamento con alfa interferone in pazienti con epatopatia cronica anti-HCV positiva.